ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Income from Continuing Operations of 1311433.0 for Q1 2026, down 26.55% YoY from 1785377.24 in Q1 2025, and up 58.62% sequentially from 3169209.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Income from Continuing Operations across 11 years of filings, most recently posting 1311433.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 26.55% year-over-year to 1311433.0; the TTM figure through Mar 2026 stood at 7302513.0 (up 25.24% YoY), while the FY2025 annual figure was 7027410.0, up 38.93% from the prior year.
- Income from Continuing Operations improved to 1311433.0 in Q1 2026, from 3169209.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for NDRA reached as high as 1036330.0 in Q1 2025 and fell as low as 4149004.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 2775700.0 (2024), against an average of 2534478.35.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations sank 184.27% — and 2025, when it jumped 62.66%.
- A 5-year view of Income from Continuing Operations shows it stood at 3289596.0 in 2022, then surged by 55.63% to 1459536.0 in 2023, then slumped by 184.27% to 4149004.0 in 2024, then increased by 23.62% to 3169209.0 in 2025, then soared by 58.62% to 1311433.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1311433.0, 3169209.0, and 1595959.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.31 Mn |
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -4.15 Mn |
| Sep 30, 2024 | -2.35 Mn |
| Jun 30, 2024 | -2.23 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -2.56 Mn |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -3.29 Mn |
| Sep 30, 2022 | -3.44 Mn |
| Jun 30, 2022 | -3.59 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Dec 31, 2021 | -3.10 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Jun 30, 2021 | -3.20 Mn |